Oncobell Program
Oncobell is a multidisciplinary research program within IDIBELL dedicated to understanding the molecular mechanisms underlying cancer and advancing innovative experimental therapies. It brings together research groups spanning the full spectrum of cancer research, from frontier basic science to translational and clinical research, fostering connections across disciplines and research stages.
At the heart of Oncobell is a shared commitment to improving patient outcomes. This goal is pursued through complementary perspectives: from understanding molecular mechanisms and signalling pathways to addressing disease-specific challenges and unmet clinical needs. By bringing these perspectives together, Oncobell creates an environment that fosters new ideas and accelerates the translation of scientific discoveries, strengthening the path from the laboratory to the clinic.
The program also promotes collaboration and networking both within IDIBELL and with external partners, with the aim of increasing scientific impact, facilitating knowledge and technology transfer, and expanding opportunities for competitive research funding. Through this integrated approach, Oncobell seeks to contribute to advances in cancer prevention, diagnosis, treatment, and patient care.
Oncobell Program
Oncobell is a multidisciplinary research program within IDIBELL dedicated to understanding the molecular mechanisms underlying cancer and advancing innovative experimental therapies. It brings together research groups spanning the full spectrum of cancer research, from frontier basic science to translational and clinical research, fostering connections across disciplines and research stages.
At the heart of Oncobell is a shared commitment to improving patient outcomes. This goal is pursued through complementary perspectives: from understanding molecular mechanisms and signalling pathways to addressing disease-specific challenges and unmet clinical needs. By bringing these perspectives together, Oncobell creates an environment that fosters new ideas and accelerates the translation of scientific discoveries, strengthening the path from the laboratory to the clinic.
The program also promotes collaboration and networking both within IDIBELL and with external partners, with the aim of increasing scientific impact, facilitating knowledge and technology transfer, and expanding opportunities for competitive research funding. Through this integrated approach, Oncobell seeks to contribute to advances in cancer prevention, diagnosis, treatment, and patient care.
The Symposium
4th International Symposium: “Novel avenues in cancer prevetion, diagnosis and treatment”
The 4th International ONCOBELL Symposium, “Novel avenues in cancer prevention, diagnosis and treatment,” will bring together leading researchers, clinicians, and experts from academia and industry to discuss emerging approaches across the cancer research. The scientific program will explore tumor prevention and progression, tumor heterogeneity and plasticity, innovative therapies and drug development, and advanced immunotherapies, combining keynote lectures, scientific sessions, short talks, poster presentations, and roundtable discussions. The symposium aims to foster scientific exchange, interdisciplinary collaboration, and new connections between basic, translational, and clinical research.
The Symposium
4th International Symposium: “Novel avenues in cancer prevetion, diagnosis and treatment”
The 4th International ONCOBELL Symposium, “Novel avenues in cancer prevention, diagnosis and treatment,” will bring together leading researchers, clinicians, and experts from academia and industry to discuss emerging approaches across the cancer research. The scientific program will explore tumor prevention and progression, tumor heterogeneity and plasticity, innovative therapies and drug development, and advanced immunotherapies, combining keynote lectures, scientific sessions, short talks, poster presentations, and roundtable discussions. The symposium aims to foster scientific exchange, interdisciplinary collaboration, and new connections between basic, translational, and clinical research.
Organizing Committee
Isabel Fabregat
Alvaro Aytes
Ernest Nadal
Josep Maria Piulats
Antonio Gentilella
Elisa Espinet
Sonia Pernas
Juan José Rojas
Barbara Rivera
Paula Sànchez
Ramón Salazar
Purificación Muñoz
Organizing Committee
Isabel Fabregat
Alvaro Aytes
Ernest Nadal
Josep Maria Piulats
Antonio Gentilella
Elisa Espinet
Sonia Pernas
Juan José Rojas
Barbara Rivera
Paula Sànchez
Ramón Salazar
Purificación Muñoz
Scientific Advisory Committee
Cristina Santos
Isabel Fabregat
Alvaro Aytes
Antonio Gentilella
Elisa Espinet
Sonia Pernas
Juan José Rojas
Barbara Rivera
Purificación Muñoz
Scientific Advisory Committee
Cristina Santos
Isabel Fabregat
Alvaro Aytes
Antonio Gentilella
Elisa Espinet
Sonia Pernas
Juan José Rojas
Barbara Rivera
Purificación Muñoz